Search results
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 4 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 5 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 10 hours agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 4 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 2 days agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 1 hour agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 5 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 4 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...